Cargando…
A Recombinant Measles Vaccine with Enhanced Resistance to Passive Immunity
Current measles vaccines suffer from poor effectiveness in young infants due primarily to the inhibitory effect of residual maternal immunity on vaccine responses. The development of a measles vaccine that resists such passive immunity would strongly contribute to the stalled effort toward measles e...
Autores principales: | Julik, Emily, Reyes-del Valle, Jorge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5691617/ https://www.ncbi.nlm.nih.gov/pubmed/28934110 http://dx.doi.org/10.3390/v9100265 |
Ejemplares similares
-
Measles at Work: Status of Measles Vaccination at a Multinational Company
por: Moussli, Nora, et al.
Publicado: (2019) -
Vaccine platform recombinant measles virus
por: Mühlebach, Michael D.
Publicado: (2017) -
Reverse Genetics of Measles Virus and Resulting Multivalent Recombinant Vaccines: Applications of Recombinant Measles Viruses
por: Billeter, M. A., et al.
Publicado: (2009) -
Development of Recombinant Measles Virus-Based Vaccines
por: Mühlebach, Michael D., et al.
Publicado: (2016) -
A Survey of Vaccine-Induced Measles IgG Antibody Titer to Verify Temporal Changes in Response to Measles Vaccination in Young Adults
por: Sasaki, Hiraku, et al.
Publicado: (2019)